Vir Biotechnology Cash from Financing (TTM) Analysis

Vir Biotechnology Inc (VIR)

8.57 -0.40 (-4.46%) USD | NASDAQ | Apr 15, 16:00

8.56 -0.01 (-0.12%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	7.48M
September 30, 2023	7.811M
June 30, 2023	9.519M
March 31, 2023	9.42M
December 31, 2022	34.76M
September 30, 2022	38.42M
June 30, 2022	40.06M
March 31, 2022	40.51M
December 31, 2021	100.33M

Date	Value
September 30, 2021	94.40M
June 30, 2021	415.08M
March 31, 2021	616.89M
December 31, 2020	529.47M
September 30, 2020	659.83M
June 30, 2020	337.26M
March 31, 2020	131.92M
December 31, 2019	449.24M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

7.48M

Minimum

Dec 2023

659.83M

Maximum

Sep 2020

207.20M

Average

94.40M

Median

Sep 2021

Cash from Financing (TTM) Benchmarks